ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

AGE AgeX Therapeutics Inc

11.10
0.00 (0.00%)
25 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
AgeX Therapeutics Inc AGE AMEX Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 11.10 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
11.10 11.10
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
22/3/202416:27GLOBEAgeX Therapeutics Reports Fourth Quarter and Annual 2023..
07/3/202415:49EDGAR2Form 425 - Prospectuses and communications, business..
07/3/202415:47EDGAR2Form 8-K - Current report
07/3/202406:47EDGAR2Form SC 13D/A - General statement of acquisition of..
14/2/202415:01EDGAR2Form SC 13D/A - General statement of acquisition of..
13/2/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
06/2/202415:05EDGAR2Form 8-K - Current report
05/2/202406:19EDGAR2Form SC 13D/A - General statement of acquisition of..
19/1/202415:05EDGAR2Form 8-K - Current report
17/1/202415:19EDGAR2Form SC 13D/A - General statement of acquisition of..
16/1/202408:11EDGAR2Form S-4/A - Registration of securities, business..
11/1/202415:05EDGAR2Form 8-K - Current report
09/1/202415:16EDGAR2Form SC 13D/A - General statement of acquisition of..
05/1/202415:05EDGAR2Form 8-K - Current report
28/12/202315:02EDGAR2Form 8-K - Current report
18/12/202315:25EDGAR2Form 8-K - Current report
13/12/202316:11EDGAR2Form SC 13D/A - General statement of acquisition of..
08/12/202315:05EDGAR2Form 8-K - Current report
01/12/202315:05EDGAR2Form 8-K - Current report
17/11/202315:05EDGAR2Form 8-K - Current report
16/11/202315:01EDGAR2Form SC 13D/A - General statement of acquisition of..
15/11/202308:38EDGAR2Form DEF 14A - Other definitive proxy statements
14/11/202315:25EDGAR2Form 8-K - Current report
14/11/202315:05BWAgeX Therapeutics Reports Third Quarter 2023 Financial..
07/11/202315:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/11/202315:05EDGAR2Form DEF 14A - Other definitive proxy statements
06/11/202315:05EDGAR2Form 8-K - Current report
01/11/202315:28EDGAR2Form SC 13D/A - General statement of acquisition of..
06/10/202315:05EDGAR2Form 8-K - Current report
22/9/202315:05EDGAR2Form PRE 14A - Other preliminary proxy statements
15/9/202315:05EDGAR2Form 8-K - Current report
08/9/202315:05EDGAR2Form 8-K - Current report
30/8/202315:05EDGAR2Form 425 - Prospectuses and communications, business..
30/8/202306:20EDGAR2Form 8-K - Current report
30/8/202306:00BWSerina Therapeutics and AgeX Therapeutics Enter into Merger..
25/8/202315:05EDGAR2Form 8-K - Current report
24/8/202315:48EDGAR2Form SC 13D/A - General statement of acquisition of..
14/8/202315:25EDGAR2Form 8-K - Current report
14/8/202315:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202315:05BWAgeX Therapeutics Reports Second Quarter 2023 Financial..
04/8/202315:05EDGAR2Form 8-K - Current report
24/7/202317:28BWAgeX Therapeutics Closes $36,000,000 Debt Exchange for..
21/7/202316:32BWAgeX Therapeutics Announces $36,000,000 Debt Exchange for..
21/7/202316:29EDGAR2Form 8-K - Current report
07/7/202315:05EDGAR2Form 8-K - Current report
23/5/202315:05BWAgeX Therapeutics Announces Appeal of NYSE American..
12/5/202315:05BWAgeX Therapeutics Reports First Quarter 2023 Financial..

Su Consulta Reciente

Delayed Upgrade Clock